vs
Eightco Holdings Inc.（ORBS）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
Eightco Holdings Inc.的季度营收约是Profound Medical Corp.的1.7倍（$10.2M vs $6.0M），Profound Medical Corp.净利率更高（-136.8% vs -2281.6%，领先2144.9%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
ORBS vs PROF — 直观对比
营收规模更大
ORBS
是对方的1.7倍
$6.0M
净利率更高
PROF
高出2144.9%
-2281.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.2M | $6.0M |
| 净利润 | $-232.5M | $-8.2M |
| 毛利率 | -13.0% | 66.8% |
| 营业利润率 | -475.0% | -123.3% |
| 净利率 | -2281.6% | -136.8% |
| 营收同比 | -49.9% | — |
| 净利润同比 | -9183.3% | — |
| 每股收益（稀释后） | $-2.34 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORBSPROF
| Q4 25 | $10.2M | $6.0M | ||
| Q3 25 | $5.3M | $5.1M | ||
| Q2 25 | $7.6M | $2.0M | ||
| Q1 25 | $9.9M | $2.3M | ||
| Q4 24 | $20.3M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $5.3M | — | ||
| Q1 24 | $8.0M | — |
净利润ORBSPROF
| Q4 25 | $-232.5M | $-8.2M | ||
| Q3 25 | $-25.8M | $-8.0M | ||
| Q2 25 | $-1.2M | $-15.7M | ||
| Q1 25 | $-2.5M | $-10.7M | ||
| Q4 24 | $-2.5M | — | ||
| Q3 24 | $-3.2M | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $1.9M | — |
毛利率ORBSPROF
| Q4 25 | -13.0% | 66.8% | ||
| Q3 25 | -3.7% | 77.7% | ||
| Q2 25 | 16.4% | 81.7% | ||
| Q1 25 | 8.2% | 79.2% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 26.5% | — | ||
| Q2 24 | 25.1% | — | ||
| Q1 24 | 17.5% | — |
营业利润率ORBSPROF
| Q4 25 | -475.0% | -123.3% | ||
| Q3 25 | -116.9% | -176.2% | ||
| Q2 25 | -15.9% | -696.9% | ||
| Q1 25 | -14.3% | -477.0% | ||
| Q4 24 | -11.9% | — | ||
| Q3 24 | -29.1% | — | ||
| Q2 24 | -16.4% | — | ||
| Q1 24 | -39.6% | — |
净利率ORBSPROF
| Q4 25 | -2281.6% | -136.8% | ||
| Q3 25 | -487.6% | -157.7% | ||
| Q2 25 | -15.4% | -792.3% | ||
| Q1 25 | -25.7% | -458.1% | ||
| Q4 24 | -12.3% | — | ||
| Q3 24 | -52.5% | — | ||
| Q2 24 | 84.2% | — | ||
| Q1 24 | 24.4% | — |
每股收益（稀释后）ORBSPROF
| Q4 25 | $-2.34 | $0.27 | ||
| Q3 25 | $-0.58 | $0.26 | ||
| Q2 25 | $-0.38 | $0.52 | ||
| Q1 25 | $-0.84 | $0.36 | ||
| Q4 24 | $-1.44 | — | ||
| Q3 24 | $-1.77 | — | ||
| Q2 24 | $2.15 | — | ||
| Q1 24 | $1.42 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $58.5M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $232.6M | $66.4M |
| 总资产 | $250.2M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ORBSPROF
| Q4 25 | $58.5M | $59.7M | ||
| Q3 25 | $23.7M | $24.8M | ||
| Q2 25 | $696.3K | $35.2M | ||
| Q1 25 | $434.4K | $46.4M | ||
| Q4 24 | $239.2K | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $363.1K | — | ||
| Q1 24 | $808.8K | — |
总债务ORBSPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ORBSPROF
| Q4 25 | $232.6M | $66.4M | ||
| Q3 25 | $339.2M | $32.1M | ||
| Q2 25 | $8.9M | $39.3M | ||
| Q1 25 | $9.7M | $50.8M | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $13.0M | — | ||
| Q2 24 | $13.8M | — | ||
| Q1 24 | $3.9M | — |
总资产ORBSPROF
| Q4 25 | $250.2M | $77.5M | ||
| Q3 25 | $355.5M | $42.3M | ||
| Q2 25 | $48.7M | $49.7M | ||
| Q1 25 | $47.6M | $60.9M | ||
| Q4 24 | $50.8M | — | ||
| Q3 24 | $49.2M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $50.2M | — |
负债/权益比ORBSPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.0M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | — |
| 自由现金流率自由现金流/营收 | -107.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ORBSPROF
| Q4 25 | $-11.0M | $-6.6M | ||
| Q3 25 | $-1.6M | $-9.6M | ||
| Q2 25 | $-659.2K | $-13.7M | ||
| Q1 25 | $999.8K | $-8.3M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $77.7K | — | ||
| Q2 24 | $-440.3K | — | ||
| Q1 24 | $-723.3K | — |
自由现金流ORBSPROF
| Q4 25 | $-11.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-661.3K | — | ||
| Q1 25 | $999.7K | — | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $73.0K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ORBSPROF
| Q4 25 | -107.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -8.7% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | -32.7% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ORBSPROF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ORBSPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.10× | — | ||
| Q1 24 | -0.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
